Assignee
MEREO BIOPHARMA 4 LTD
GB·0 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0157US2023190723A1Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiencyMEREO BIOPHARMA 4 LTD·Filed 2021·Application pending·0 cites
- 0254US2023218596A1Methods involving neutrophil elastase inhibitor alvelestat for treating coronavirus infectionMEREO BIOPHARMA 4 LTD·Filed 2021·Application pending·0 cites
- 0345US2024382472A1Neutrophil elastase inhibitors for use in the treatment of fibrosisMEREO BIOPHARMA 4 LTD·Filed 2022·Application pending·0 cites
- 0436US2022354833A1Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host diseaseMEREO BIOPHARMA 4 LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEREO BIOPHARMA 4 LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →